| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V5459 | NANVURANLAT (JPH203) | 1037592-40-7 | JPH203 (KYT-0353; JPH-203) is a novel and potentanti-cancer drug targeting L-type amino acid transporter 1 (LAT1), which plays a primary role in the uptake of essential amino acids in tumor cells. |
|
V117730 | SLC6A19-IN-2 | 3102931-05-2 | SLC6A19-IN-2 (Example 4) is a potent SLC6A19 inhibitor with an IC50 of 14 nM. |
|
V114820 | SLC6A19-IN-3 | 3104477-57-5 | SLC6A19-IN-3 (compound 83-P1-P2) is a highly potent, selective, and orally effective SLC6A19 inhibitor with an IC50 value of 28 nM. |
|
V111103 | SLC6A19-IN-4 | 2962069-39-0 | SLC6A19-IN-4 is an allosteric competitive oral active BOAT1 (SLC6A19) inhibitor. |
|
V111158 | SLC6A19-IN-5 | 3107360-12-0 | SLC6A19-IN-5 (Example 25) is an SLC6A19 inhibitor with an IC50 of 11 nM. |
|
V4245 | V-9302 | 1855871-76-9 | V-9302 (V9302) is a novel, potent, competitive, selective antagonist of transmembrane glutamine flux, specifically, ASCT2 inhibitor, with anticancer activity. |